@Miri Mo I will continue to research each item above to see if any more available than DON, which still might be the gold standard.

@Candy Shackelford I read the articles and listen to podcasts, but not sure where it slots in the process of (1) rebuilding mitochondria (2) strengthening our immune system to better deal with cancer (3) eradicating pathogens which are involved with the whole model of origin of cancer (4) increasing ROS, and how it might help HBOT (5) increasing cognitive function. I’m sure there are more benefits, but these 5 have all been cited in the medical literature.

Great result. I will definitely seek out providers in my area for the therapy.

@Rob Henderson Hi Rob, I’ve done therapeutic keto for several months and seen some of my spinal Mets go inactive (less than a 2.0 SUV rating after PET/CT scan), then added Tagrisso, a targeted drug specific to the EGFR marker/muttation, and had SBRT radiation last June on the 3 remaining tumors at T7,8 and L2, completely eradicating them as seen on recent rescan MRI of my full spine and PET/CT scan this week at MDA, in Houston. Hoverever, I developed more FDG active spots at T2, S2, occipital condyle, right iliac crest, and the primary nodule in my left upper lung lobe. Now I feel like I’m playing “wack-a-mole”, knowing that additional SBRT can eradicate them, but the present plan is to do a biopsy and run genetic testing for the 2nd time, looking to see if additional genetic markers, like the MET marker, can be identified, etc. This is all Standard Of Care (SOC), from my MDA docs, but I will continue on my keto diet, and redouble my efforts and repeat my HBOT sessions, having finished 40 a couple months ago. I got very encouraged the first few months as I saw regression of tumors as a applied Dr Seyfried’s protocol and did my 40 HBOT sessions. I won’t get discouraged, but as I continue to study and receive additional avenues of approach from all the folks in this group, I will keep moving forward. That is all any of us can do. I wrote to AlphaTau, and Dr. Robert Ben, who gave a podcast about the DART procedure that AlphaTau has developed in Israel, asking to be accepted into there clinical trial underway in Israel. All of our goal is to work toward remission and do whatever it takes to stay there. Helping each other by reciting the real truth of our efforts, positive and negative results, and asking questions is how we help each other. There are no dumb questions, and no one has “arrived”. It is a journey, a marathon, and an attempt to learn more about ourselves and the human condition. I am humbled by being the recipient of all the prayers offered up by so many people, and in return, I hope to be a source of strength, encouragement, and knowledge gained by other people, so that I can be a conduit of all I have received.

Dr. Sanjay Juneja is a well-known podcaster, having interviewed Dr. Seyfried and many others. He is a triple-board certified oncologist based in Baton Rouge, LA. After listening to him, I will call to schedule an appointment. Even though I am being seen at MD Anderson, considered the #1 cancer research-based treatment center worldwide, I have not met a single doctor here that is conducive to metabolic treatment, but are all SOC adherents.

@Maup Enthoven About DRP-104 Our lead glutamine antagonist, DRP -104, is currently in early stage clinical development. The mechanisms of action for DRP-104 include: a) direct inhibition of tumor cell addiction to glutamine leading to substantial single agent activity and tumor regression; b) broad metabolic remodeling of the tumor microenvironment leading to enhanced anti-tumor immune activity; and, c) stimulation of T effector, NK and NKT cells and inhibition of immunosuppressive MDSC and macrophage cells, leading to greater long-term durable responses and survival. https://www.dracenpharma.com/dracen-announces-two-drp-104-presentations-at-aacr/

@Maup Enthoven available for sale: https://www.selleckchem.com/products/sirpiglenastat.html